Sign In
Buy BMRN
$54.66
+1.34 (+2.51%)
At Close: Jun 03, 2026
What Makes BioMarin (BMRN) a New Buy Stock
01:00pm, Monday, 07'th Apr 2025
BioMarin (BMRN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
BMRN vs. CSLLY: Which Stock Is the Better Value Option?
12:40pm, Monday, 07'th Apr 2025
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of BioMarin Pharmaceutical (BMRN) and CSL Limited Sponsored ADR (CSLLY). But which of these
BioMarin Pharmaceutical: Pegasus Success May Lead To Palynziq Label Expansion
03:37pm, Thursday, 03'rd Apr 2025
BioMarin Pharmaceutical Inc.'s primary endpoint was met in the phase 3 Pegasus study, which used Palynziq for the treatment of adolescent patients ages 12 - 17 with phenylketonuria. The company is set
BMRN's PKU Drug Palynziq Meets Goal in Late-Stage Pediatric Study
11:15am, Thursday, 03'rd Apr 2025
Based on the late-stage data, BioMarin plans to submit a regulatory filing for expanding the label of its PKU drug Palynziq in adolescents before this year's end.
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock
10:50am, Wednesday, 02'nd Apr 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
BioMarin Announces Positive Pivotal Data for PALYNZIQ® (pegvaliase-pqpz) in Adolescents with Phenylketonuria
09:00am, Wednesday, 02'nd Apr 2025
Company plans to submit for regulatory approval later this year SAN RAFAEL, Calif. , April 2, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the Phase 3 PEGASUS
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Momentum Stock
10:50am, Friday, 28'th Mar 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
5 Historically Cheap Growth Stocks to Buy With Confidence in the Wake of the Nasdaq Correction
05:06am, Thursday, 27'th Mar 2025
Every so often, Wall Street sends a not-so-subtle reminder to investors that stocks can move in both directions.
BioMarin (BMRN) Up 4.2% Since Last Earnings Report: Can It Continue?
12:36pm, Friday, 21'st Mar 2025
BioMarin (BMRN) reported earnings 30 days ago. What's next for the stock?
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock
11:10am, Friday, 21'st Mar 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
BioMarin Presents New Data Demonstrating Favorable Safety and Strong Adherence in Real-World Clinical Practice with VOXZOGO® (vosoritide) in Children Under 3 with Achondroplasia at 2025 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
09:00am, Thursday, 20'th Mar 2025
New data also to be presented for PALYNZIQ® (pegvaliaise-pqpz), reinforcing its value in sustaining blood Phe level reduction and improving health-related quality of life for adults with phenylketonu
BMRN vs. CSLLY: Which Stock Should Value Investors Buy Now?
12:40pm, Tuesday, 18'th Mar 2025
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either BioMarin Pharmaceutical (BMRN) or CSL Limited Sponsored ADR (CSLLY). But which of these two s
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock
10:50am, Monday, 17'th Mar 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Buy These 5 Top-Ranked Stocks to Play Likely Earnings Beat
09:25am, Wednesday, 12'th Mar 2025
Top-ranked stocks Doximity (DOCS), Life Time Group Holdings (LTH), Adtalem Global Education (ATGE), BioMarin Pharmaceutical (BMRN) and Iridium Communications (IRDM) are likely to beat on the bottom li
4 Discounted PEG Stocks Offering the Best Returns to Value Investors
09:46am, Monday, 10'th Mar 2025
Here we present four discounted PEG stocks that qualify our screening criteria, TAP, BMRN, DVN and JAZZ.
